DouglasEMeslerMDMPH

Nephrology • Tewksbury, MA

Nephrology Associates of the Merrimack Valley

Join to view full profile

Dr. Mesler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Mesler's full profile

Already have an account?

Office
600 Clark Road
Second Floor
Tewksbury, MA 01876
Phone+1 978-453-1811
Is this information wrong?

Education & Training

Boston University Medical CenterFellowship, Nephrology, 1991 - 1994
Boston University Medical CenterResidency, Internal Medicine, 1987 - 1991
University of North Carolina at Chapel Hill School of MedicineClass of 1987

Certifications & Licensure

MA State Medical License 1989 - 2025
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

22 citations
Management of chronic kidney disease in an academic primary care clinic.
Ajay K. Israni, Cynthia A. Korzelius, Raymond R. Townsend, Douglas Mesler> ;American Journal of Nephrology. 2003 Jan 1
3 citations
Survival analysis using Medicare data: example and methods.
Beth A Virnig, Arlene S. Ash, Sara Kind, Douglas E. Mesler> ;Health Services Research. 2000 Dec 1
4 citations
How much better can we predict dialysis patient survival using clinical data
Douglas E. Mesler, Susan Byrne-Logan, Ellen P. McCarthy, Arlene S. Ash, Mark A. Moskowitz> ;Health Services Research. 1999 Apr 1
28 citations
Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment
Douglas E. Mesler, Ellen P. McCarthy, Susan Byrne-Logan, Arlene S. Ash, Mark A. Moskowitz> ;The American Journal of Medicine. 1999 Mar 1
6 citations
Primary hyperaldosteronism causing posttransplantation hypertension: Localization by adrenal vein sampling
Fahmy Hi, Melby Jc, Douglas E. Mesler, Robert M. Beazley, Cho Si, Beldon A. Idelson> ;American Journal of Kidney Diseases. 1998 May 1
21 citations
Measuring, Managing, and Improving the Quality of End-Stage Renal Disease Care
Norman G. Levinsky, Douglas E. Mesler> ;American Journal of Kidney Diseases. 1994 Aug 1
17 citations
Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: a report of a case and a review of the literature.
Gregory Gardner, Douglas Mesler, Hillel J. Gitelman> ;Renal Failure. 1989 Jan 1
International endstage renal disease (ESRD) outcome comparisons.
Mesler, D. E.> ;J Ren Nutr. 1998 Oct
Magnetic resonance angiography in the evaluation of living-related renal donors.
Gourlay, W. A., Yucel, E. K., Hakaim, A. G., O'Meara, Y. M., Mesler, D. E., Kerr, K., Cho, S. I.> ;Transplantation. 1995 Dec 15
Photodynamic effects of erythrosine on the smooth muscle cells of guinea-pig taenia coli.
Matthews, E. K., Mesler, D. E.> ;Br J Pharmacol. 1984 Oct
1,25-Dihydroxyvitamin D3 activates secretion of hydrogen peroxide by human monocytes.
Cohen, M. S., Mesler, D. E., Snipes, R. G., Gray, T. K.> ;J Immunol. 1986 Feb 1
Join now to see all

Grant Support

Hypertensive Heart Disease In END Stage Renal Disease PopulationNational Center For Research Resources2001
Hypertensive Heart Disease In END Stage Renal DiseaseNational Center For Research Resources2000
Case MIX Models For END Stage Renal Disease PatientsNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2000